Exit Stage Left: As Pfizer Merger Nears, Wyeth Ends its Partnership with Progenics
This article was originally published in The Pink Sheet Daily
Executive Summary
Ahead of completion of its merger with Pfizer, Wyeth essentially is paying its partner to take back the low-earning constipation drug.